Oseltamivir, a neuraminidase (NA) inhibitor, is currently the most widely used antiviral drug for influenza worldwide. The emergence of primary oseltamivir-resistant mutations in NA protein of ...

Antiviral resistance stemming from rapid viral evolution and adaptation is a major challenge faced in treating viral infections. Here, we describe the mechanisms and factors underlying antiviral ...

Nirsevimab (Beyfortus), an antibody targeting respiratory syncytial virus (RSV), is indicated for newborns and infants to prevent bronchiolitis. Available since September 2023, its widespread use may ...

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with drug-resistant infections in 2022. While there is still no vaccine for the ...

Tamiflu, the same antiviral used to treat ordinary seasonal influenza, is the front line medication recommended for treating highly pathogenic bird flu (Photo by Rui Vieira/PA Images via Getty Images) ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The virus that causes COVID-19 might be becoming resistant to antiviral ...

HIV resistant to lenacapavir pays a big price Yet some of the most formidable resistance mutations came with a measurable fitness cost. Under standard laboratory conditions, those viral variants ...

An electronic 96-channel pipette was one of the tools used to scale up and allow the teamto perform over 7,000 parallel experiments that uncovered more than 100 bNAb escapemutations across 15 viral ...

Chinese researchers have identified a key mutation in the Ebola virus that may explain why one of the deadliest outbreaks in recent history spread so widely and persisted for so long. Their findings ...

Gloved fingers hold a labeled vial of lenacapavir, a clear, yellowish liquid. Lenacapavir (shown) is an antiretroviral medication used to help prevent and treat HIV. Credit: Associated Press While ...